Business

KPMG 'sued for £723m' over botched audit of US-listed Chinese biotech firm

Published

KPMG ‘sued for £723m’ over botched audit of US-listed Chinese biotech firm that collapsed in 2012

By Daily Mail City & Finance Reporter

Published: | Updated:

Scandal-ridden KPMG is being sued for a reported £723million over its audit of a US-listed Chinese biotechnology company that collapsed in 2012.

The auditor’s ‘appalling’ work allegedly allowed China Medical Technologies to carry out a ‘brazen’ £348million accounting fraud, a court in Hong Kong was told.

Liquidators at restructuring firm Borrelli Walsh said KPMG failed to ask ‘obvious’ questions that would have ‘easily’ exposed the fraud, according to the Financial Times. 

Fresh scandal: 'KPMG's appalling' work allegedly allowed China Medical Technologies to carry out a 'brazen' £348m accounting fraud, a court in Hong Kong was told

Fresh scandal: ‘KPMG’s appalling’ work allegedly allowed China Medical Technologies to carry out a ‘brazen’ £348m accounting fraud, a court in Hong Kong was told

They are asking for as much as £395million to cover an alleged misappropriation of cash and dividends plus interest of more than £327million.

Nasdaq-listed China Medical Technologies was put into liquidation in 2012 by courts in the Cayman Islands, New York and Hong Kong, after fraud accusations. 

A KPMG spokesman said: ‘While the hearing is in progress, we are not able to comment.’

Some links in this article may be affiliate links. If you click on them we may earn a small commission. That helps us fund This Is Money, and keep it free to use. We do not write articles to promote products. We do not allow any commercial relationship to affect our editorial independence.

source: dailymail.co.uk